SELLAS Life Sciences Group Earnings
NASDAQ: SLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.65+0.39 (+3.46%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
SELLAS Life Sciences Group earnings summary
In its most recent report on Jul 27, 2026 (Q2 2026), SLS posted EPS of $-0.05. Across the last 16 reports, SLS shares moved an average of 11.5% (in either direction) in the first trading session after results, rising 9 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
SLS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 27, 2026 | — | $-0.05 | — | +20.0% |
| May 12, 2026 | — | $-0.05 | — | +9.9% |
| Jan 8, 2026 | — | $-0.05 | — | +15.0% |
| Nov 12, 2025 | — | $-0.06 | — | +7.0% |
| Aug 12, 2025 | — | $-0.07 | — | +17.2% |
| May 13, 2025 | — | $-0.07 | — | +16.0% |
| Mar 20, 2025 | — | $-0.06 | — | -7.5% |
| Nov 13, 2024 | — | $-0.10 | — | -11.4% |
| Aug 13, 2024 | — | $-0.13 | — | 0.0% |
| May 14, 2024 | — | $-0.21 | — | -4.1% |
| Mar 28, 2024 | — | $-0.23 | — | +32.7% |
| Nov 9, 2023 | — | $-0.33 | — | +8.8% |
| Aug 10, 2023 | — | $-0.31 | — | -2.6% |
| May 11, 2023 | — | $-0.47 | — | +15.1% |
| Mar 16, 2023 | — | $-0.33 | — | -8.9% |
| Nov 14, 2022 | — | $-0.34 | — | -8.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.